
Results
2
2 companies
MedinCell
Market Cap: €865.5m
Engages in the research and development of biodegradable polymer-based processes for the controlled and prolonged delivery of active pharmaceutical ingredients into the human body and animals in France.
MEDCL
€24.10
7D
0%
1Y
37.8%
DBV Technologies
Market Cap: €700.1m
A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.
DBV
€2.37
7D
-3.4%
1Y
35.4%